The report will be delivered in 2-3 business days.

Metabolic Disorders Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030

Starting Price : $ 5000.00 | Pages : 300 | Published : December 2020 | SKU CODE : 8383 | Format :


The metabolic disorders drugs market consists of sales of metabolic disorders drugs and related services by entities (organizations, sole traders and partnerships) that produce metabolic disorders drugs to treat metabolic diseases. This industry includes establishments that produce drugs such as insulin, pramlintide and other drugs to treat diabetes, anti-thyroid drugs to treat hyperthyroidism, and other drugs to treat pituitary gland, adrenal gland and parathyroid gland disorders. The metabolic disorders drugs market is segmented into anti diabetic drugs; anti-thyroid drugs; and others (hyperparathyroidism, hypopituitarism, hypoadrenalism).

The global metabolic disorders drugs market is expected to grow from $143.16 billion in 2020 to $146.25 billion in 2021 at a compound annual growth rate (CAGR) of 2.2%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $198.07 billion in 2025 at a CAGR of 8%.

North America was the largest region in the global metabolic disorders drugs market, accounting for 54% of the market in 2020. Asia Pacific was the second largest region, accounting for 24% of the global metabolic disorders drugs market. Africa was the smallest region in the global metabolic disorders drugs market.

The rise in sedentary jobs, busy lifestyles and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as diabetes and obesity. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of metabolic disorders. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. These factors are expected to increase the patient pool globally, thereby driving the metabolic disorders drugs market during the forecast period.

Regulatory agencies and federal governments adopted stringent regulations and took a tough stance on drug pricing by pharmaceutical companies during the historic period. Pharmaceutical companies faced criticism from politicians, patients and physicians over high pricing of some medicines and drugs. Moreover, companies had to sell drugs and medicines at subsidized rates to government hospitals, doctors and clinics, further effecting companies’ revenues. This led to drug manufacturing companies operating on a reduced profit margin, which negatively impacted the attractiveness of the metabolic disorders drugs industry in the historic period.

Companies are focusing on employing artificial intelligence applications to revolutionize the treatment of metabolic disorders. Artificial Intelligence is a machine-based learning which makes use of human intelligence functionalities like reasoning and problem-solving abilities to obtain insights and provide useful information. This technology radically changes the treatment of metabolic syndrome by analyzing large sets of chemical and biological data to identify potential drug candidates with higher success rates and at a quicker pace when compared to human analysis. 3BIGS, a Korean biodata analysis-based company that studies the relation between diseases, targets and drugs is using AI technology to help researches repurpose the drugs for additional diseases.

The major players covered in the global metabolic disorders drugs market are Sanofi S.A, Novo Nordisk A/S, AstraZeneca Plc, Johnson & Johnson, Merck & Co.

The countries covered in the global metabolic disorders drugs market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global metabolic disorders drugs market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global metabolic disorders drugs market is segmented -

1) By Type: Anti Diabetics drugs, Anti-Thyroid Drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route Of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

    1. Executive Summary

    2. Report Structure

    3. Metabolic Disorders Drugs Market Characteristics

    3.1. Market Definition

    3.2. Key Segmentations

    4. Metabolic Disorders Drugs Market Product Analysis

    4.1. Leading Products/ Services

    4.2. Key Features and Differentiators

    4.3. Development Products

    5. Metabolic Disorders Drugs Market Supply Chain

    5.1. Supply Chain

    5.2. Distribution

    5.3. End Customers

    6. Metabolic Disorders Drugs Market Customer Information

    6.1. Customer Preferences

    6.2. End Use Market Size and Growth

    7. Metabolic Disorders Drugs Market Trends And Strategies

    8. Impact Of COVID-19 On Metabolic Disorders Drugs

    9. Metabolic Disorders Drugs Market Size And Growth

    9.1. Market Size

    9.2. Historic Market Growth, Value ($ Billion)

    9.2.1. Drivers Of The Market

    9.2.2. Restraints On The Market

    9.3. Forecast Market Growth, Value ($ Billion)

    9.3.1. Drivers Of The Market

    9.3.2. Restraints On The Market

    10. Metabolic Disorders Drugs Market Regional Analysis

    10.1. Global Metabolic Disorders Drugs Market, 2020, By Region, Value ($ Billion)

    10.2. Global Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region

    10.3. Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region

    11. Metabolic Disorders Drugs Market Segmentation

    11.1. Global Metabolic Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Anti Diabetics drugs

    Anti-Thyroid Drugs

    Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)

    11.2. Global Metabolic Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies/ Drug Stores

    Others

    11.3. Global Metabolic Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Oral

    Parenteral

    Others

    11.4. Global Metabolic Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Branded Drugs

    Generic Drugs

    11.5. Global Metabolic Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Prescription-Based Drugs

    Over-The-Counter Drugs

    12. Metabolic Disorders Drugs Market Metrics

    12.1. Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2015-2025, Global

    12.2. Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2015-2025, Global

    13. Asia-Pacific Metabolic Disorders Drugs Market

    13.1. Asia-Pacific Metabolic Disorders Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    13.2. Asia-Pacific, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)

    13.3. Asia-Pacific, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    13.4. Asia-Pacific, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    13.5. Asia-Pacific, Metabolic Disorders Drugs Market Metrics

    13.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Asia-Pacific Countries

    13.6. Asia-Pacific Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7. Asia-Pacific Metabolic Disorders Drugs Market: Country Analysis

    13.7.1. China Metabolic Disorders Drugs Market

    13.7.1.1. China Metabolic Disorders Drugs Market Overview

    13.7.1.2. China Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.1.3. China Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.2. Australia Metabolic Disorders Drugs Market

    13.7.2.1. Australia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.2.2. Australia Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.3. Hong Kong Metabolic Disorders Drugs Market

    13.7.3.1. Hong Kong Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.4. India Metabolic Disorders Drugs Market

    13.7.4.1. India Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.4.2. India Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.5. Indonesia Metabolic Disorders Drugs Market

    13.7.5.1. Indonesia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.5.2. Indonesia Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.6. Japan Metabolic Disorders Drugs Market

    13.7.6.1. Japan Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.6.2. Japan Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.7. Malaysia Metabolic Disorders Drugs Market

    13.7.7.1. Malaysia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.8. New Zealand Metabolic Disorders Drugs Market

    13.7.8.1. New Zealand Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.9. Philippines Metabolic Disorders Drugs Market

    13.7.9.1. Philippines Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.10. Singapore Metabolic Disorders Drugs Market

    13.7.10.1. Singapore Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.11. South Korea Metabolic Disorders Drugs Market

    13.7.11.1. South Korea Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.11.2. South Korea Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.12. Thailand Metabolic Disorders Drugs Market

    13.7.12.1. Thailand Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.13. Vietnam Metabolic Disorders Drugs Market

    13.7.13.1. Vietnam Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14. Western Europe Metabolic Disorders Drugs Market

    14.1. Western Europe Metabolic Disorders Drugs Market Overview

    14.2. Western Europe, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)

    14.3. Western Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    14.4. Western Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    14.5. Western Europe, Metabolic Disorders Drugs Market Metrics

    14.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Western Europe Countries

    14.6. Western Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7. Western Europe Metabolic Disorders Drugs Market: Country Analysis

    14.7.1. Austria Metabolic Disorders Drugs Market

    14.7.1.1. Austria Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.2. Belgium Metabolic Disorders Drugs Market

    14.7.2.1. Belgium Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.3. Denmark Metabolic Disorders Drugs Market

    14.7.3.1. Denmark Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.4. Finland Metabolic Disorders Drugs Market

    14.7.4.1. Finland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.5. France Metabolic Disorders Drugs Market

    14.7.5.1. France Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.5.2. France Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.6. Germany Metabolic Disorders Drugs Market

    14.7.6.1. Germany Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.6.2. Germany Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.7. Ireland Metabolic Disorders Drugs Market

    14.7.7.1. Ireland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.8. Italy Metabolic Disorders Drugs Market

    14.7.8.1. Italy Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.9. Netherlands Metabolic Disorders Drugs Market

    14.7.9.1. Netherlands Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.10. Norway Metabolic Disorders Drugs Market

    14.7.10.1. Norway Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.11. Portugal Metabolic Disorders Drugs Market

    14.7.11.1. Portugal Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.12. Spain Metabolic Disorders Drugs Market

    14.7.12.1. Spain Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.13. Sweden Metabolic Disorders Drugs Market

    14.7.13.1. Sweden Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.14. Switzerland Metabolic Disorders Drugs Market

    14.7.14.1. Switzerland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.15. UK Metabolic Disorders Drugs Market

    14.7.15.1. UK Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.15.2. UK Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15. Eastern Europe Metabolic Disorders Drugs Market

    15.1. Eastern Europe Metabolic Disorders Drugs Market Overview

    15.2. Eastern Europe, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)

    15.3. Eastern Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    15.4. Eastern Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    15.5. Eastern Europe, Metabolic Disorders Drugs Market Metrics

    15.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Eastern Europe Countries

    15.6. Eastern Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7. Eastern Europe Metabolic Disorders Drugs Market: Country Analysis

    15.7.1. Czech Republic Metabolic Disorders Drugs Market,  

    15.7.1.1. Czech Republic Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.2. Poland Metabolic Disorders Drugs Market

    15.7.2.1. Poland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.3. Romania Metabolic Disorders Drugs Market

    15.7.3.1. Romania Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.4. Russia Metabolic Disorders Drugs Market

    15.7.4.1. Russia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.4.2. Russia Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16. North America Metabolic Disorders Drugs Market

    16.1. North America Metabolic Disorders Drugs Market Overview

    16.2. North America, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)

    16.3. North America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    16.4. North America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    16.5. North America, Metabolic Disorders Drugs Market Metrics

    16.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, North America Countries

    16.6. North America Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7. North America Metabolic Disorders Drugs Market: Country Analysis

    16.7.1. Canada Metabolic Disorders Drugs Market

    16.7.1.1. Canada Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7.2. Mexico Metabolic Disorders Drugs Market

    16.7.2.1. Mexico Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7.3. USA Metabolic Disorders Drugs Market

    16.7.3.1. USA Metabolic Disorders Drugs Market Overview

    16.7.3.2. USA Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7.3.3. USA Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17. South America Metabolic Disorders Drugs Market

    17.1. South America Metabolic Disorders Drugs Market Overview

    17.2. South America, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)

    17.3. South America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    17.4. South America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    17.5. South America, Metabolic Disorders Drugs Market Metrics

    17.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, South America Countries

    17.6. South America Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7. South America Metabolic Disorders Drugs Market: Country Analysis

    17.7.1. Argentina Metabolic Disorders Drugs Market

    17.7.1.1. Argentina Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.2. Brazil Metabolic Disorders Drugs Market

    17.7.1.1. Brazil Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.2.2. Brazil Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.3. Chile Metabolic Disorders Drugs Market

    17.7.3.1. Chile Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.4. Colombia Metabolic Disorders Drugs Market

    17.7.4.1. Colombia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.5. Peru Metabolic Disorders Drugs Market

    17.7.5.1. Peru Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.6. Venezuela Metabolic Disorders Drugs Market

    17.7.6.1. Venezuela Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18. Middle East Metabolic Disorders Drugs Market

    18.1. Middle East Metabolic Disorders Drugs Market Overview

    18.2. Middle East, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)

    18.3. Middle East, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    18.4. Middle East, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    18.5. Middle East, Metabolic Disorders Drugs Market Metrics

    18.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Middle East Countries

    18.6. Middle East Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7. Middle East Metabolic Disorders Drugs Market: Country Analysis

    18.7.1. Saudi Arabia Metabolic Disorders Drugs Market

    18.7.1.1. Saudi Arabia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7.2. Israel Metabolic Disorders Drugs Market

    18.7.2.1. Israel Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7.3. Turkey Metabolic Disorders Drugs Market

    18.7.3.1. Turkey Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7.4. UAE Metabolic Disorders Drugs Market

    18.7.4.1. UAE Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19. Africa Metabolic Disorders Drugs Market

    19.1. Africa Metabolic Disorders Drugs Market Overview

    19.2. Africa, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)

    19.3. Africa, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    19.4. Africa, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    19.5. Africa, Metabolic Disorders Drugs Market Metrics

    19.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Africa Countries

    19.6. Africa Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19.7. Africa Metabolic Disorders Drugs Market: Country Analysis

    19.7.1. Egypt Metabolic Disorders Drugs Market

    19.7.1.1. Egypt Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19.7.2. Nigeria Metabolic Disorders Drugs Market

    19.7.2.1. Nigeria Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19.7.3. South Africa Metabolic Disorders Drugs Market

    19.7.3.1. South Africa Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    20. Metabolic Disorders Drugs Market Competitive Landscape

    20.1. Competitive Market Overview

    20.2. Market Shares

    20.3. Company Profiles

    20.3.1. Sanofi S.A

    20.3.1.1. Company Overview

    20.3.1.2. Products And Services

    20.3.1.3. Strategy

    20.3.1.4. Financial Performance

    20.3.2. Novo Nordisk A/S

    20.3.2.1. Company Overview

    20.3.2.2. Products And Services

    20.3.2.3. Strategy

    20.3.2.4. Financial Performance

    20.3.3. AstraZeneca Plc

    20.3.3.1. Company Overview

    20.3.3.2. Products And Services

    20.3.3.3. Strategy

    20.3.3.4. Financial Performance

    20.3.4. Johnson & Johnson

    20.3.4.1. Company Overview

    20.3.4.2. Products And Services

    20.3.4.3. Strategy

    20.3.4.4. Financial Performance

    20.3.5. Merck & Co

    20.3.5.1. Company Overview

    20.3.5.2. Products And Services

    20.3.5.3. Strategy

    20.3.5.4. Financial Performance

    21. Key Mergers And Acquisitions In The Metabolic Disorders Drugs Market

    22. Market Background: Pharmaceutical Drugs Market

    22.1. Pharmaceutical Drugs Market Characteristics

    22.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F Growth, By Segment, Value ($ Billion), Global

    22.3. Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)

    22.4. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region

    22.5. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)

    23. Recommendations

    23.1. Global Metabolic Disorders Drugs Market In 2025- Growth Countries

    23.2. Global Metabolic Disorders Drugs Market In 2025- Growth Segments

    23.3. Global Metabolic Disorders Drugs Market In 2025- Growth Strategies

    24. Appendix

    24.1. NAICS Definitions Of Industry Covered In This Report

    24.2. Abbreviations

    24.3. Currencies

    24.4. Research Inquiries

    24.5. The Business Research Company

    25. Copyright And Disclaimer

List Of Tables

    Table 1: Historic Market Growth, Value ($ Billion)
  • Table 2: Forecast Market Growth, Value ($ Billion)
  • Table 3: Global Metabolic Disorders Drugs Market, 2020, By Region, Value ($ Billion)
  • Table 4: Global Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Table 5: Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6: Global Metabolic Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Metabolic Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Global Metabolic Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Global Metabolic Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: Global Metabolic Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2015-2025, Global
  • Table 12: Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2015-2025, Global
  • Table 13: Asia-Pacific, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 14: Asia-Pacific, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 15: Asia-Pacific, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 16: Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Asia-Pacific Countries
  • Table 17: Asia-Pacific Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 18: China Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 19: China Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 20: Australia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 21: Australia Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 22: Hong Kong Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 23: India Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 24: India Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 25: Indonesia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 26: Indonesia Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 27: Japan Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 28: Japan Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 29: Malaysia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 30: New Zealand Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 31: Philippines Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 32: Singapore Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 33: South Korea Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 34: Thailand Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 35: Vietnam Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 36: Western Europe, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 37: Western Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 38: Western Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 39: Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Western Europe Countries
  • Table 40: Western Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 41: Austria Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 42: Belgium Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 43: Denmark Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 44: Finland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 45: France Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 46: France Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 47: Germany Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 48: Germany Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 49: Ireland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 50: Italy Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 51: Netherlands Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 52: Norway Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 53: Portugal Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 54: Spain Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 55: Sweden Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 56: Switzerland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 57: UK Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 58: UK Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 59: Eastern Europe, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 60: Eastern Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 61: Eastern Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 62: Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Eastern Europe Countries
  • Table 63: Eastern Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 64: Czech Republic Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 65: Poland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 66: Romania Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 67: Russia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 68: Russia Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 69: North America, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 70: North America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 71: North America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 72: Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, North America Countries
  • Table 73: North America Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 74: Canada Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 75: Mexico Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 76: USA Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 77: USA Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 78: South America, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 79: South America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 80: South America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 81: Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, South America Countries
  • Table 82: South America Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 83: Argentina Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 84: Brazil Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 85: Brazil Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 86: Chile Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 87: Colombia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 88: Peru Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 89: Venezuela Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 90: Middle East, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 91: Middle East, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 92: Middle East, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 93: Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Middle East Countries
  • Table 94: Middle East Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 95: Saudi Arabia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 96: Israel Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 97: Turkey Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 98: UAE Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 99: Africa, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 100: Africa, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 101: Africa, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 102: Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Africa Countries
  • Table 103: Africa Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 104: Egypt Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 105: Nigeria Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 106: South Africa Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 107: Sanofi S.A Financial Performance
  • Table 108: Novo Nordisk A/S Financial Performance
  • Table 109: AstraZeneca Plc Financial Performance
  • Table 110: Johnson & Johnson Financial Performance
  • Table 111: Merck & Co Financial Performance
  • Table 112: Pharmaceutical Drugs Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Table 113: Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)
  • Table 114: Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Table 115: Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Table 116: Global Metabolic Disorders Drugs Market In 2025- Growth Countries
  • Table 117: Global Metabolic Disorders Drugs Market In 2025- Growth Segments
  • Table 118: Global Metabolic Disorders Drugs Market In 2025- Growth Strategies

List Of Figures

    Figure 1: Historic Market Growth, Value ($ Billion)
  • Figure 2: Forecast Market Growth, Value ($ Billion)
  • Figure 3: Global Metabolic Disorders Drugs Market, 2020, By Region, Value ($ Billion)
  • Figure 4: Global Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Figure 5: Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6: Global Metabolic Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Metabolic Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Global Metabolic Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Global Metabolic Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: Global Metabolic Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2015-2025, Global
  • Figure 12: Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2015-2025, Global
  • Figure 13: Asia-Pacific, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 14: Asia-Pacific, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 15: Asia-Pacific, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 16: Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Asia-Pacific Countries
  • Figure 17: Asia-Pacific Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 18: China Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 19: China Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 20: Australia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 21: Australia Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 22: Hong Kong Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 23: India Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 24: India Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 25: Indonesia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 26: Indonesia Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 27: Japan Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 28: Japan Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 29: Malaysia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 30: New Zealand Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 31: Philippines Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 32: Singapore Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 33: South Korea Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 34: Thailand Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 35: Vietnam Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 36: Western Europe, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 37: Western Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 38: Western Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 39: Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Western Europe Countries
  • Figure 40: Western Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 41: Austria Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 42: Belgium Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 43: Denmark Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 44: Finland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 45: France Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 46: France Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 47: Germany Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 48: Germany Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 49: Ireland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 50: Italy Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 51: Netherlands Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 52: Norway Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 53: Portugal Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 54: Spain Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 55: Sweden Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 56: Switzerland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 57: UK Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 58: UK Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 59: Eastern Europe, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 60: Eastern Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 61: Eastern Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 62: Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Eastern Europe Countries
  • Figure 63: Eastern Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 64: Czech Republic Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 65: Poland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 66: Romania Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 67: Russia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 68: Russia Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 69: North America, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 70: North America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 71: North America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 72: Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, North America Countries
  • Figure 73: North America Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 74: Canada Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 75: Mexico Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 76: USA Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 77: USA Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 78: South America, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 79: South America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 80: South America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 81: Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, South America Countries
  • Figure 82: South America Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 83: Argentina Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 84: Brazil Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 85: Brazil Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 86: Chile Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 87: Colombia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 88: Peru Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 89: Venezuela Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 90: Middle East, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 91: Middle East, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 92: Middle East, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 93: Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Middle East Countries
  • Figure 94: Middle East Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 95: Saudi Arabia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 96: Israel Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 97: Turkey Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 98: UAE Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 99: Africa, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 100: Africa, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 101: Africa, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 102: Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Africa Countries
  • Figure 103: Africa Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 104: Egypt Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 105: Nigeria Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 106: South Africa Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 107: Sanofi S.A Financial Performance
  • Figure 108: Novo Nordisk A/S Financial Performance
  • Figure 109: AstraZeneca Plc Financial Performance
  • Figure 110: Johnson & Johnson Financial Performance
  • Figure 111: Merck & Co Financial Performance
  • Figure 112: Pharmaceutical Drugs Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Figure 113: Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)
  • Figure 114: Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Figure 115: Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Figure 116: Global Metabolic Disorders Drugs Market In 2025- Growth Countries
  • Figure 117: Global Metabolic Disorders Drugs Market In 2025- Growth Segments
  • Figure 118: Global Metabolic Disorders Drugs Market In 2025- Growth Strategies
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Cough And Cold Preparations Global Market Report 2021: COVID 19 Implications And Growth to 2030
View Report
Diabetes Therapies Market - By Segments (Injectables And Oral), Trends, Key Players, Opportunities And Strategies – Global Forecast To 2023
View Report
Blood Cancer Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030
View Report
Antiglaucoma Drugs Market - By Product Type (Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication, Others), By Disease Condition Type (Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Congenital Glaucoma, Other Types Of Glaucoma), By Prescription Type (OTC Drugs, Prescription Drugs), And By Region, Opportunities And Strategies – Global Antiglaucoma Drugs Market Forecast To 2030
View Report
Brain Tumor Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030
View Report
Cervical Cancer Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030
View Report
AntiThyroid Drugs Global Market Report 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)